Does Humana Cover Prolia? Costs, Part B vs. Part D, and Prior Authorization

Yes, Humana does cover Prolia on its Medicare plans, though what you pay depends on whether the drug is billed under Part B or Part D and on your specific plan’s rules. Humana’s 2026 Medicare Part B step therapy list treats Prolia as a preferred osteoporosis drug, so you don’t have to try other medications first.1Humana. 2026 Part B Step Therapy Preferred Drug List For Part D members, the average out-of-pocket cost runs about $274 per dose every six months, or roughly $46 a month.2Prolia HCP. Pharmacy Benefit for Prolia

Part B or Part D: Why the Billing Pathway Matters

Prolia is an injection given by a healthcare professional once every six months, and the way your provider obtains the drug determines which part of Medicare pays. If the doctor orders Prolia from a distributor and administers it in the office, it’s billed as a medical benefit under Medicare Part B. If the doctor gets it through a pharmacy, it’s billed as a pharmacy benefit under Medicare Part D.3Prolia. Paying for Prolia

Under Part B, Medicare pays 80% after you meet your annual deductible, and you’re responsible for the remaining 20% coinsurance. If you also carry supplemental coverage like Medigap, that 20% is often picked up for you, which is why many patients with supplemental insurance end up paying $0 per injection once their deductible is met.3Prolia. Paying for Prolia

Under Part D, your cost depends on the drug’s tier, which pharmacy you use, and where you are in the Medicare drug benefit stages for the year.4Humana. Humana Comprehensive Drug Guide 2026 Humana designates CenterWell Specialty Pharmacy as its preferred specialty pharmacy for Prolia, and using it can mean lower cost-sharing than a non-preferred specialty pharmacy. Humana Medicare Advantage members should verify their specific cost with Humana directly, since plans vary.3Prolia. Paying for Prolia

Preferred Status and Prior Authorization

On Humana’s 2026 Medicare Part B step therapy preferred drug list, Prolia (HCPCS code J0897) is classified as “Preferred” in the osteoporosis category. That means Humana won’t require you to try alternatives like bisphosphonates first; step therapy applies to the nonpreferred drugs instead.1Humana. 2026 Part B Step Therapy Preferred Drug List

Across Medicare Part D plans generally, about 96% of patients have Prolia on their formulary, and nearly eight in ten face no step therapy edit and no prior authorization requirement.2Prolia HCP. Pharmacy Benefit for Prolia Still, your particular Humana plan may apply prior authorization or other utilization management. You can check with Humana’s online prior authorization search tool or the provider-facing resources on Humana’s site.5Humana Provider. Prior Authorization Lists

What Prolia Costs With Humana

Retail pricing without insurance is roughly $2,507 for a single 60 mg dose, which works out to about $5,000 a year before administration fees.6GoodRx. How Much Is Prolia Without Insurance

With Humana Medicare coverage, the picture changes significantly. Through Medicare Part D, the average out-of-pocket cost comes to about $274 per dose, or roughly $46 a month.2Prolia HCP. Pharmacy Benefit for Prolia Under Part B with supplemental insurance, many patients pay nothing per injection after the annual deductible.3Prolia. Paying for Prolia

How To Check Coverage on Your Specific Plan

Formulary placement, tier, and cost-sharing differ from one Humana plan to the next, so the only way to know your real cost is to check your own plan. A few ways to do that:

  • Log in to your MyHumana account and search for Prolia to see estimated pricing on your plan.7Humana. Medicare Drug List
  • Use Humana’s Medicare Drug List Search tool online, which lets you select your plan and look up the drug.8Humana Medicare Advantage. Medicare Formulary
  • Download your plan’s Prescription Drug Guide. Group Medicare members should look at the Prescription Drug Guide section inside their Evidence of Coverage.7Humana. Medicare Drug List
  • Call Customer Care at the number on the back of your member ID card, or call Humana Clinical Pharmacy Review at 800-555-2546 for a coverage determination.8Humana Medicare Advantage. Medicare Formulary

If Humana Denies Prolia

You have a layered appeals process when a request is denied.

Your prescriber can request a formulary exception, a waiver of step therapy, or a lower cost-sharing tier by contacting Humana Clinical Pharmacy Review at 800-555-2546 or faxing 877-486-2621. Standard requests get an answer within 72 hours; expedited requests, when health is at risk, within 24 hours.9Humana Provider. Exceptions and Appeals

If the initial request is denied, you have 65 calendar days from the denial notice to file an appeal (a redetermination). Standard appeals are decided within seven calendar days, expedited appeals within 72 hours.9Humana Provider. Exceptions and Appeals

If Humana upholds the denial, you can take it to an independent review organization, C2C Innovative Solutions Inc., within 65 calendar days of Humana’s appeal decision.9Humana Provider. Exceptions and Appeals

A Note on the Manufacturer Copay Card

Amgen runs the Amgen SupportPlus Co-Pay Program, which can bring costs as low as $0 per dose. If you have Humana Medicare, you won’t qualify. The program is limited to commercially insured patients and specifically excludes anyone whose prescription is paid in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state healthcare program. Patients already enrolled who move onto Medicare are required to call Amgen SupportPlus at 1-833-442-6436 to end their participation.10Amgen SupportPlus. Co-Pay Card Program Terms and Conditions

Medicare patients who need help can still contact Amgen SupportPlus at 866-264-2778, which offers financial support information and a guide called “Understanding Medicare Options.”11Amgen SupportPlus. Prolia Osteoporosis If your income is limited, you may also qualify for Medicare Extra Help, which reduces prescription drug costs.6GoodRx. How Much Is Prolia Without Insurance

Biosimilars May Shift Coverage

The denosumab market is changing fast. By early 2026, the FDA had approved ten biosimilar versions of Prolia and its oncology counterpart Xgeva, with four already on the U.S. market.12Center for Biosimilars. FDA Approves Amneal Denosumab Biosimilars Humana’s 2026 Part B step therapy list keeps Prolia as “Preferred” while classifying several biosimilars as “Nonpreferred.”1Humana. 2026 Part B Step Therapy Preferred Drug List Humana’s formulary policies note, though, that when biosimilars enter the formulary, the plan may apply new restrictions to the original biologic, move it to a different tier, or both.13Humana. Humana Prescription Drug Guide 2026 Watch for formulary updates on your plan, because coverage and cost-sharing for Prolia could shift as the biosimilar market matures.